SCHEMBL21614761

SCHEMBL21614761

FC(F)(F)c1cc(SCc2ccn(-c3ccc(Cl)cc3)n2)ccn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 1/20 0.37
▸ AR P10275 1/20 0.37
▸ PTGS2 P35354 3/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ RECQL P46063 1/20 0.36
▸ MAPT P10636 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ PKM P14618 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ LMNA P02545 2/20 0.33
▸ RXRA P19793 1/20 0.33
▸ GRIN1 Q05586 1/20 0.33
▸ GRIN2B Q13224 1/20 0.33
▸ LOXL2 Q9Y4K0 2/20 0.33
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21611954 0.83 RXRA (0.48) PTGS2PTGS1MAPTKCNH2RXRA
SCHEMBL21611969 0.76 PTGS2 (0.36) PTGS2PTGS1NPC1RAB9AMAPT
SCHEMBL21614743 0.75 DAO (0.38) PTGS2PTGS1NPC1RAB9ARECQL
SCHEMBL21614754 0.73 NOTUM (0.50) KCNH2RXRAGRIN1GRIN2B
SCHEMBL21614706 0.72 CYP3A4 (0.46) PTGS2KCNH2RXRAGRIN1GRIN2B
SCHEMBL21614685 0.72 NOTUM (0.51) PTGS2PTGS1KCNH2RXRAGRIN1
SCHEMBL21611981 0.70 PTGS2 (0.53) PTGS2NPC1RAB9AMAPTNPSR1
SCHEMBL31364581 0.70 MAPT (0.54) KDM1APTGS2PTGS1NPC1RAB9A
SCHEMBL21614744 0.68 HDAC1 (0.36) LOXL2CYP3A4CYP2C19CYP2C9LOX
SCHEMBL21611945 0.67 LOXL2 (0.38) RXRAGRIN1GRIN2BLOXL2LOX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 KDM1A 2987/4885AR 1673/4885PTGS2 820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback